Patent ID: 9186393
Filing Date: 2015-11-17
Classification: A61K,A61P,C12Y,G01N

Abstract:
1. A method of reducing blood glucose in a subject in need thereof, comprising administering to the subject a pharmaceutical composition comprising a unit dosage comprising an effective amount to reduce the blood glucose of the subject of a specific activator of mitogen-activated protein kinase selected from the group consisting of mitogen-activated protein kinase 3 (MKK3), mitogen-activated protein kinase kinase 4 (MKK4), mitogen-activated protein kinase kinase 6 (MKK6), p38 mitogen-activated protein kinase (p38MAPK), mitogen-activated kinase-activated protein kinase 2 (MK2), and combinations thereof, and a pharmaceutically acceptable carrier for injection.